ALDH1+ CSCs downregulate the TAP gene and CD80, thereby targeting the antigen presentation pathway (84), while the CD44+/CD24− group upregulates the expression of CXCR4 which is involved in EMT and the induction of the CSC phenotype in BC (83, 85, 86). The gene discussed is CD44; the disease is breast cancer.